SP Industries and Ecodyst Announce Partnership to Distribute Single Sample Evaporation Systems
SP Industries recently announced a distribution partnership agreement with Ecodyst Inc., benefitting both companies evaporation equipment.
SP Industries recently announced a distribution partnership agreement with Ecodyst Inc. (1). According to the press release, during sample preparation, evaporation is used when samples need to be dried before being analyzed. Ecodyst offers a full range of single sample evaporators from benchtop to industrial models. Those models all reportedly provide self-cooling condenser technology for maximum efficiency, lower environmental impact, and sample quality. If multiple samples require to be dried, SP Genevac parallel centrifugal evaporators reportedly eradicate the solvent drying bottleneck in the drug discovery and synthetic organic chemistry laboratory. The systems are equipped with Genevac Dri-Pure patented anti-bumping technology, ranging from benchtop to high throughput scale and are proven to be capable of removing the most difficult solvent mixtures without compromising sample purity or integrity.
“This new partnership enables our SP Genevac brand to be the comprehensive, one-stop-shop for all evaporation solutions,” said SP Industries CEO Brian Larkin in the company’s press release (1). “Ecodyst's revolutionary single sample evaporator line complements our SP Genevac world-renowned centrifugal evaporators for parallel sample evaporation and together lets us work with customers more effectively to help streamline and accelerate the drug discovery process.”
George Adjabeng, CEO of Ecodyst commented (1) that his company is passionate about their innovative devices for the laboratory equipment industry. “This new partnership with SP is a significant milestone for Ecodyst and it will enable us to make these products available to more customers worldwide,” said Adjabeng (1).
"We are excited to partner with a like-minded organization that approaches product design with a keen understanding of the needs and challenges facing today's customers. Having a broader offering that includes single sample evaporators is particularly relevant for those engaged in pharmaceutical and cannabis sample preparation workflows,” said Larkin (1).
Reference:
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
